# Morpholine as a privileged scaffold for neurodegenerative disease therapeutics

## TL;DR

Morpholine compounds show promise as a drug scaffold for treating neurodegenerative and mental health disorders due to their ability to target key brain enzymes and pathways.

## Contribution

This study systematically reviews the pharmacological potential of morpholine derivatives in central nervous system drug development.

## Key findings

- Morpholine derivatives inhibit monoamine oxidases and cholinesterases effectively.
- They demonstrate improved blood–brain barrier permeability and balanced lipophilic–hydrophilic properties.
- Morpholine compounds often outperform conventional drugs in selectivity and efficacy.

## Abstract

Morpholine, a six-membered heterocyclic ring containing oxygen and nitrogen, is increasingly recognized in medicinal chemistry for its diverse pharmacological properties. Morpholine derivatives have shown promise as enzyme inhibitors, neurotransmitter modulators, and receptor agonists, making them candidates for treating neurodegenerative and neuropsychiatric disorders. The importance of this study lies in elucidating the therapeutic significance of morpholine in central nervous system (CNS) drug development, particularly in its role in inhibiting monoamine oxidases (MAO-A and MAO-B) and cholinesterases (AChE and BChE) and targeting the norepinephrine and dopamine pathways. Systematic searches of peer-reviewed literature were conducted to evaluate the structural significance and pharmacological potential of morpholine-based compounds. The findings reveal that morpholine derivatives exhibit promising efficacy and selectivity, often outperforming conventional drugs in specific contexts. These discoveries point to the possibility of morpholine as a valuable scaffold in CNS drug discovery due to its balanced lipophilic–hydrophilic profile and enhanced blood–brain barrier permeability. The implications of these findings are significant, and they call for future research to focus on optimizing morpholine derivatives to improve selectivity, efficacy, and safety, thereby expanding their therapeutic potential in CNS applications. Overall, this study emphasizes the importance of morpholine derivatives in advancing CNS therapeutics and their potential role in addressing unmet medical needs in neuropsychiatric disorder treatments.

The review emphasizes the importance of morpholine derivatives in advancing CNS therapeutics and their potential role in addressing unmet medical needs in neuropsychiatric disorder treatments.